Sanofi SA
Company Profile
Business description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Contact
46, avenue de la Great Army
Paris 75017
FRAT: +33 153774000
E: investor.relations@sanofi.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
87,994
Stocks News & Analysis
stocks
3 shares with high dividend yields from our Global Best Ideas list
video
Our view of mining shares
stocks
Undervalued ASX share with robust cash flow
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,208.60 | 42.20 | 0.52% |
| CAC 40 | 7,598.63 | 23.39 | -0.31% |
| DAX 40 | 18,557.70 | 150.63 | 0.82% |
| Dow JONES (US) | 40,455.41 | 39.97 | 0.10% |
| FTSE 100 | 8,167.37 | 31.41 | -0.38% |
| HKSE | 17,469.36 | 166.52 | -0.94% |
| NASDAQ | 18,035.77 | 28.20 | 0.16% |
| Nikkei 225 | 39,594.39 | 4.61 | -0.01% |
| NZX 50 Index | 12,425.58 | 115.67 | 0.94% |
| S&P 500 | 5,567.46 | 3.05 | 0.05% |
| S&P/ASX 200 | 7,971.10 | 39.40 | 0.50% |
| SSE Composite Index | 2,915.37 | 48.85 | -1.65% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Alumina Ltd AWC | 1.45 | 0.03 | -1.69% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Droneshield Ltd DRO | 1.42 | 0.13 | -8.39% |
| Zip Co Ltd ZIP | 1.80 | 0.11 | 6.19% |
| Core Lithium Ltd CXO | 0.10 | 0.00 | -2.00% |
| South32 Ltd S32 | 2.98 | 0.01 | -0.33% |
| Spartan Resources Ltd SPR | 1.23 | 0.24 | 23.62% |
| Pilbara Minerals Ltd PLS | 2.89 | 0.00 | 0.00% |
| Imugene Ltd IMU | 0.06 | 0.00 | 7.14% |
| Mesoblast Ltd MSB | 1.31 | 0.15 | 12.99% |